Arterial Hypertension and Sepsis

Revista Portuguesa de Cardiologia

Volumn 22, Issue 11, 2003, Pages 1375-1379

  Nunes, José Pedro L ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Arterial hypertension; Blacks; Sepsis

Indexed keywords

AGED; CAUCASIAN; COMORBIDITY; HEART DISEASE; HUMAN; HYPERTENSION; INFECTION; MORTALITY; NEGRO; NONHUMAN; OUTCOMES RESEARCH; PREVALENCE; RAT; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK;

AFRICAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERTENSION; SEPSIS;

EID: 0347992900     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Centers for disease control. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987. JAMA 1990;263:937-8.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
3. Bernard C, Merval R, Esposito B, Tedgui A. Resistance to endotoxin shock in spontaneously hypertensive rats. Hypertension 1998;31:1350-6.
4. Nunes JPL. Effects of lipopolysaccharide on vascular reactivity and mortality in rats. Autonom Autacoid Pharmacol 2002;22:247-52.
5. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
6. Folkow B. The structural factor in hypertension with special emphasis on the altered geometric design of the systemic resistance arteries. In: Hypertension: Pathophysiology, diagnosis and treatment. 2nd edition. Laragh JH, Brenner BM, editors. New York: Raven Press 1995;481-502.
7. Veterans administration cooperative study on anti-hypertensive agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.
8. The management committee. The Australian therapeutic trial in mild hypertension. Lancet 1980;8181:1261-7.
9. Medical Research Council working party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985;291:97-102.
10. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-62.
11. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. JAMA 1979;242:2562-71.
12. Hypertension Detection and Follow-up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 1988;259:2113-22.
13. Smith GD, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. Lancet 1998;351:934-9.
14. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med 2002;347:1585-92.
15. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome and associated costs of care. Crit Care Med 2001;29:1303-10.
16. Ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000;46:650-7.
17. Wilson TW, Grim CE. Biohistory of slavery and blood pressure differences in blacks today. A hypothesis. Hypertension 1991;18(I Suppl):I122-I128.
18. Kaplan NM. Kaplan's Clinical Hypertension. 8th edition. Philadelphia: Lippincott Williams and Wilkins, 2002.
19. Helmer OM. Renin-angiotensin system and its relation to hypertension. Prog Cardiovasc Dis 1965;8:117-28.
20. Ferreira AV, Viana MC, Mill JG, Asmar RG, Cunha RS. Racial differences in aortic stiffness in normotensive and hypertensive adults. J Hypertens 1999;17:631-7.
21. Stein CM, Lang CC, Singh I, He HB, Wood AJJ. Increased vascular adrenergic vasoconstriction and decreased vascular vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity. Hypertension 2000;36:945-51.
22. Curtin PD. The slavery hypothesis for hypertension among African Americans: the historical evidence. Am J Public Health 1992;82:1681-6.
23. Miller JC. Way of death. Merchant capitalism and the Angolan slave trade 1730-1830. The University of Wisconsin Press 1988.
24. Fogel RW, Engerman SL. Time on the cross. The Economics of American Negro Slavery. New York: WW Norton, 1989, page 121 (first published in 1974).
25. Nabel EG. Cardiovascular disease. N Engl J Med 2003; 349:60-72.
26. Grim CE, Robinson M. Salt, slavery and survival - Hypertension in the African diaspora. Epidemiology 2003; 14:120-2.
27. Blackburn H. The slavery hypothesis of hypertension among African-Americans. Epidemiology 2003;14:118-9.
28. Darwin C. The origin of species by means of natural selection or the preservation of favoured races in the struggle for life. London: Penguin Books, 1985, page 130-131 (first published in 1859).